How Iceland's approach to teen drinking and drug use is being rolled out here

Faced with teens drinking alcohol and using drugs at higher rates than others in the province, a local health unit will try ...

Arcutis Canada Announces Health Canada Approval of ZORYVE® Foam 0.3%, the First Steroid-Free Topical Foam for Scalp and Body Psoriasis, for Adults an…

Once-daily, steroid-free topical foam intentionally formulated to help manage psoriasis across difficult-to-treat areas of ...

With respiratory virus season under way, here’s what to know about RSV vaccines and protection

RSV is a leading cause of infant hospitalizations in Canada, with older people and those who are immunocompromised also at greater risk ...

Arcutis Announces Publication of Positive Long-Term Safety and Efficacy Data of ZORYVE® (roflumilast) Foam 0.3% in Individuals with Seborrheic Dermatitis in American Journal ...

Detailed price information for Arcutis Biotherapeutics Inc (ARQT-Q) from The Globe and Mail including charting and trades.